Annals of Surgical Oncology Sign the Guestbook
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by DeMatteo, R. P.
Right arrow Articles by Barker, C. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by DeMatteo, R. P.
Right arrow Articles by Barker, C. F.

Annals of Surgical Oncology, Vol 6, Issue 1 88-94, Copyright © 1999 by Society of Surgical Oncology


ARTICLES

Cellular immunity delimits adenoviral gene therapy strategies for the treatment of neoplastic diseases

R. P. DeMatteo, H. Yeh, M. Friscia, D. Caparrelli, C. Burke, N. Desai, G. Chu, J. F. Markmann, S. E. Raper and C. F. Barker
Department of Surgery, Hospital of the University of Pennsylvania, Philadelphia, USA.

BACKGROUND: Adenoviral gene therapy is a promising new approach for the treatment of neoplastic diseases. To design rational clinical trials and distinguish the effects of therapeutic transgene expression from those caused by viral infection alone, the immune response to the vector must be understood. In these experiments, we further define cellular immunity to recombinant adenovirus. METHODS: The immune response to hepatic adenoviral gene transfer was studied in infected mice by depleting T cells with an anti-CD3 antibody, measuring splenocyte cytokine production, determining the impact of transgene expression on inflammation, and assessing liver MHC protein expression. RESULTS: The cellular immune response to recombinant adenovirus is (1) averted by T lymphocyte depletion, (2) marked by a TH1 response with increased IL-2 production, (3) directed against both the transgene product and viral proteins, and (4) associated with increased hepatocyte MHC Class I expression. CONCLUSIONS: It is necessary to take into consideration the constraints imposed by the immunogenicity of recombinant adenovirus and its transient transgene expression in the clinical application of adenoviral gene transfer for the treatment of cancer.


This article has been cited by other articles:


Home page
JNMHome page
K. I. Kim, J. H. Kang, J.-K. Chung, Y. J. Lee, J. M. Jeong, D. S. Lee, and M. C. Lee
Doxorubicin Enhances the Expression of Transgene Under Control of the CMV Promoter in Anaplastic Thyroid Carcinoma Cells
J. Nucl. Med., September 1, 2007; 48(9): 1553 - 1561.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J. L. Brandsma, M. Shlyankevich, L. Zhang, M. D. Slade, E. C. Goodwin, W. Peh, and A. B. Deisseroth
Vaccination of Rabbits with an Adenovirus Vector Expressing the Papillomavirus E2 Protein Leads to Clearance of Papillomas and Infection
J. Virol., January 1, 2004; 78(1): 116 - 123.
[Abstract] [Full Text] [PDF]


Home page
Arch Otolaryngol Head Neck SurgHome page
H. Kojima, M. Iida, H. Miyazaki, T. Koga, H. Moriyama, and Y. Manome
Enhancement of Cytarabine Sensitivity in Squamous Cell Carcinoma Cell Line Transfected With Deoxycytidine Kinase
Arch Otolaryngol Head Neck Surg, June 1, 2002; 128(6): 708 - 713.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
N. D. Tran, C. D. Porada, G. Almeida-Porada, H. A. Glimp, W. F. Anderson, and E. D. Zanjani
Induction of stable prenatal tolerance to {beta}-galactosidase by in utero gene transfer into preimmune sheep fetuses
Blood, June 1, 2001; 97(11): 3417 - 3423.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
W. Budts, P. Pokreisz, Z. Nong, N. Van Pelt, H. Gillijns, R. Gerard, R. Lyons, D. Collen, K. D. Bloch, and S. Janssens
Aerosol Gene Transfer With Inducible Nitric Oxide Synthase Reduces Hypoxic Pulmonary Hypertension and Pulmonary Vascular Remodeling in Rats
Circulation, December 5, 2000; 102(23): 2880 - 2885.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
B. W. Tillman, T. L. Hayes, T. D. deGruijl, J. T. Douglas, and D. T. Curiel
Adenoviral Vectors Targeted to CD40 Enhance the Efficacy of Dendritic Cell-based Vaccination against Human Papillomavirus 16-induced Tumor Cells in a Murine Model
Cancer Res., October 1, 2000; 60(19): 5456 - 5463.
[Abstract] [Full Text]


Home page
Clin. Cancer Res.Home page
D. T. Curiel
The Development of Conditionally Replicative Adenoviruses for Cancer Therapy
Clin. Cancer Res., September 1, 2000; 6(9): 3395 - 3399.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
P. R. Dash, M. L. Read, K. D. Fisher, K. A. Howard, M. Wolfert, D. Oupicky, V. Subr, J. Strohalm, K. Ulbrich, and L. W. Seymour
Decreased Binding to Proteins and Cells of Polymeric Gene Delivery Vectors Surface Modified with a Multivalent Hydrophilic Polymer and Retargeting through Attachment of Transferrin
J. Biol. Chem., February 11, 2000; 275(6): 3793 - 3802.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the Society of Surgical Oncology.